| # | Drug | Count |
|---|---|---|
| 0 | TOPIRAMATE | 52 |
| 1 | ACETAMINOPHEN | 36 |
| 2 | IBUPROFEN | 36 |
| 3 | ALBUTEROL SULFATE | 34 |
| 4 | IBUPFROFEN | 33 |
| 5 | IBUPROFEN 200 MG | 33 |
| 6 | IBUPROFEN 200MG | 33 |
| 7 | IBUPROFEN CAPSULE | 33 |
| 8 | IBUPROFEN CAPSULES 200 MG | 33 |
| 9 | IBUPROFEN ORAL | 33 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ALMOTRIPTAN | 11 | 0.0104 |
| 1 | FERROUS ASPARTO GLYCINATE, FERROUS FUMARATE, ASCORBIC ACID, FOLIC ACID, LEVOMEFOLATE GLUCOSAMINE, CYANOCOBALAMIN, ZINC GLYCINATE, AND INTRINSIC FACTOR | 1 | 0.0102 |
| 2 | DIHYDROERGOTAMINE MESYLATE | 11 | 0.0082 |
| 3 | BUTALBITAL, ASPIRIN, AND CAFFEINE | 1 | 0.0058 |
| 4 | UBROGEPANT | 22 | 0.0035 |
| 5 | ORPHENADRINE CITRATE | 2 | 0.0032 |
| 6 | BETAMETHASONE ACETATE AND BETAMETHASONE SODIUM PHOSPHATE | 1 | 0.0025 |
| 7 | TOPICAL ANESTHETIC | 2 | 0.0025 |
| 8 | RIZATRIPTAN BENZOATE | 23 | 0.0022 |
| 9 | NALTREXONE HYDROCHLORIDE AND BUPROPION HYDROCHLORIDE | 18 | 0.0021 |
| # | Drug class | Count |
|---|---|---|
| 0 | Nonsteroidal Anti-inflammatory Drug [EPC] | 82 |
| 1 | Corticosteroid [EPC] | 43 |
| 2 | Benzodiazepine [EPC] | 36 |
| 3 | Estrogen [EPC] | 34 |
| 4 | Expectorant [EPC] | 29 |
| 5 | Calcitonin Gene-related Peptide Receptor Antagonist [EPC] | 25 |
| 6 | HMG-CoA Reductase Inhibitor [EPC] | 24 |
| 7 | Acetylcholine Release Inhibitor [EPC] | 23 |
| 8 | Neuromuscular Blocker [EPC] | 23 |
| 9 | Provitamin D2 Compound [EPC] | 22 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Calcitonin Gene-related Peptide Receptor Antagonist [EPC] | 25 | 0.0036 |
| 1 | Nitrogen Binding Agent [EPC] | 4 | 0.0017 |
| 2 | Serotonin-1b and Serotonin-1d Receptor Agonist [EPC] | 20 | 0.0008 |
| 3 | Provitamin D2 Compound [EPC] | 22 | 0.0007 |
| 4 | gamma-Aminobutyric Acid A Receptor Agonist [EPC] | 1 | 0.0006 |
| 5 | Guanylate Cyclase-C Agonist [EPC] | 1 | 0.0005 |
| 6 | Androgen [EPC] | 11 | 0.0004 |
| 7 | Insulin-like Growth Factor-1 Receptor Inhibitor [EPC] | 2 | 0.0003 |
| 8 | Acetylcholine Release Inhibitor [EPC] | 23 | 0.0002 |
| 9 | Anti-IgE [EPC] | 19 | 0.0002 |